Creating a new test to diagnose eosinophilic chronic rhinosinusitis
Official title: Development of a Diagnostic Test for Eosinophilic Chronic Rhinosinusitis
Funded at Glycomira, LLC · NIH-10917233 · Data updated 2026-11-12
This study is working on a new, easy test to check eosinophil levels in people with eosinophilic chronic rhinosinusitis (eCRS) to help doctors better understand the condition and tailor treatments without needing invasive procedures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Glycomira, LLC NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $290,351 |
| NIH project number | 5R41AI179525-02 |
| Project ID | NIH-10917233 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with eosinophilic chronic rhinosinusitis who are experiencing significant sinonasal symptoms.
✕Less likely to help
Patients with other forms of chronic rhinosinusitis that do not involve eosinophilia may not benefit from this research.
What this research studies
This research aims to develop and validate a new diagnostic test for eosinophilic chronic rhinosinusitis (eCRS) that can be used directly in clinical settings. The test focuses on measuring eosinophil levels, which are linked to the severity of the condition and treatment responses. By providing a more accessible and efficient diagnostic tool, the research seeks to improve patient outcomes and reduce the need for invasive procedures like surgical biopsies. This approach could lead to better management of eCRS and personalized treatment options for patients.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses for patients suffering from eosinophilic chronic rhinosinusitis, improving their treatment options and quality of life.
How similar studies have gone: While there have been advancements in diagnostic testing for chronic rhinosinusitis, this specific approach to diagnosing eosinophilic chronic rhinosinusitis is novel and has not been extensively tested.
Where this research is happening
-
Glycomira, LLC
Salt Lake City, United States Active
Researchers
- Principal investigator: Pulsipher, Abigail — Glycomira, LLC
- Study coordinator: Pulsipher, Abigail
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.